SOAT1 and breast cancer: In summary, we show that GHR is overexpressed in ER−ve breast cancer cells and inhibiting GHR signaling reduces the activity of the JAK/STAT and AKT/mTOR pathways and inhibits EMT, growth, and metastatic behavior of ER−ve breast cancers.